Influence of Kinesiology Taping Application on Severity of Signs and Symptoms in Breast Engorgement.

August 5, 2020 updated by: Anna Jakóbik, Żelazna Medical Centre, LLC

Influence of Kinesiology Taping Application on Severity of Signs and Symptoms in Breast Engorgement at Early Lactation Stage.

The aim of the research is to asses the efficacy of kinesiology taping application in breast engorgement in early postpartum stage.

Kinesiology application will be performed by women's health physiotherapist. Patient's perceived improvement and milk outflow following application will be assessed.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Warsaw, Poland, 01-004
        • Recruiting
        • Żelazna Medical Centre, St. Sophia Hospital
        • Contact:
          • Anna Jakóbik, PT, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • cesarian section or vaginal delivery
  • delivery between 37 and 41 gestational week
  • signs and symptoms of breast engorgement (significant increase of breast between 2nd and 10th day postpartum, pain, obstructed milk outflow)
  • VAS 4 and more
  • volume of milk outflow less than 20ml
  • 6 point self-rated engorgement scale between 3 and 6

Exclusion Criteria:

  • age less than 18 and more than 45
  • patients after extensive surgical breast intervention or having breast implants
  • allergy to kinesiology taping

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Standard care and Kinesiology taping Group
Application of elastic cotton strip with an acrylic adhesive that is used with the intent of treating pain and disability from athletic injuries and a variety of other physical disorders.
Application of elastic cotton strip with an acrylic adhesive that is used with the intent of treating pain and disability from athletic injuries and a variety of other physical disorders
No Intervention: Standard care Group
Assistance in baby feeding, manual of device-assisted (lactator) milk expression, cold compress, ibuprofen, gentle breast massage, breathing and shoulder girdle exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) change from baseline till 24 hours after intervention
Time Frame: assessment at the baseline 24 hours after intervention
Pain assesment by Visual Analogue Scale (VAS scale), range 0-10, higher numbers represents worse outcome.
assessment at the baseline 24 hours after intervention
Human milk outflow change from baseline till 24 hours after intervention
Time Frame: assessment at the baseline and 24 hours after intervention
Assesment of milk outflow based on infant body mass increase
assessment at the baseline and 24 hours after intervention
6 point self-rated breast engorgement scale
Time Frame: assessment at the baseline
assesment of breast engorgement, range 1-6, higher values represent worse outcomes
assessment at the baseline
5 point perceived improvement scale
Time Frame: assessment 24 hours after intervention
assessment of improvement of signs and symptoms of breast engorgement range 1-5, higher values represent worse outcomes
assessment 24 hours after intervention
The Breastfeeding Self-Efficacy Scale
Time Frame: assessment at the baseline
assessment of mother's attitude to breastfeeding
assessment at the baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale (VAS) change from baseline till 3 hours after intervention
Time Frame: assessment at the baseline 3 hours after intervention
Pain assesment by Visual Analogue Scale (VAS scale), range from 0-10, higher numbers represents worse outcome.
assessment at the baseline 3 hours after intervention
Human milk outflow change from baseline till 3 hours after intervention
Time Frame: assessment at the baseline and 3 hours after intervention
Assesment of milk outflow based on infant body mass increase
assessment at the baseline and 3 hours after intervention
5 point perceived improvement scale
Time Frame: assessment 3 hours after intervention
assessment of improvement of signs and symptoms of breast engorgement, range 1-5, higher values represent worse outcomes
assessment 3 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2019

Primary Completion (Anticipated)

September 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

June 5, 2019

First Submitted That Met QC Criteria

June 12, 2019

First Posted (Actual)

June 13, 2019

Study Record Updates

Last Update Posted (Actual)

August 6, 2020

Last Update Submitted That Met QC Criteria

August 5, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 24/2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lactation Disorders

Clinical Trials on Kinesiology taping application

3
Subscribe